BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30679933)

  • 1. Long noncoding RNA PXN-AS1-L promotes non-small cell lung cancer progression via regulating PXN.
    Zhang Z; Peng Z; Cao J; Wang J; Hao Y; Song K; Wang Y; Hu W; Zhang X
    Cancer Cell Int; 2019; 19():20. PubMed ID: 30679933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA PXN-AS1-L promotes the malignancy of nasopharyngeal carcinoma cells via upregulation of SAPCD2.
    Jia X; Niu P; Xie C; Liu H
    Cancer Med; 2019 Aug; 8(9):4278-4291. PubMed ID: 31173488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression.
    Yan J; Jia Y; Chen H; Chen W; Zhou X
    J Exp Clin Cancer Res; 2019 Sep; 38(1):390. PubMed ID: 31488171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer.
    Lv J; Qiu M; Xia W; Liu C; Xu Y; Wang J; Leng X; Huang S; Zhu R; Zhao M; Ji F; Xu L; Xu K; Yin R
    J Exp Clin Cancer Res; 2016 May; 35():75. PubMed ID: 27154193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel long non-coding RNA LBX2-AS1 indicates poor prognosis and promotes cell proliferation and metastasis through Notch signaling in non-small cell lung cancer.
    Tang LX; Su SF; Wan Q; He P; Xhang Y; Cheng XM
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7419-7429. PubMed ID: 31539129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Expression of Long Noncoding RNA PCNA-AS1 Promotes Non-Small-Cell Lung Cancer Cell Proliferation and Oncogenic Activity via Upregulating CCND1.
    Wu C; Zhu XT; Xia L; Wang L; Yu W; Guo Q; Zhao M; Lou J
    J Cancer; 2020; 11(7):1959-1967. PubMed ID: 32194807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA BRE-AS1 represses non-small cell lung cancer cell growth and survival via up-regulating NR4A3.
    Zhang M; Wu J; Zhong W; Zhao Z; Liu Z
    Arch Biochem Biophys; 2018 Dec; 660():53-63. PubMed ID: 30227111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZEB1-AS1 is associated with poor prognosis in non-small-cell lung cancer and influences cell migration and apoptosis by repressing ID1.
    Jin J; Wang H; Si J; Ni R; Liu Y; Wang J
    Clin Sci (Lond); 2019 Jan; 133(2):381-392. PubMed ID: 30626729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
    He R; Zhang FH; Shen N
    Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA DNAH17-AS1 promotes tumorigenesis and metastasis of non-small cell lung cancer via regulating miR-877-5p/CCNA2 pathway.
    Du LJ; Mao LJ; Jing RJ
    Biochem Biophys Res Commun; 2020 Dec; 533(3):565-572. PubMed ID: 32981678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A positive feedback loop between ZNF205-AS1 and EGR4 promotes non-small cell lung cancer growth.
    He S; Lin J; Xu Y; Lin L; Feng J
    J Cell Mol Med; 2019 Feb; 23(2):1495-1508. PubMed ID: 30556283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up‑regulation of lncRNA PXN-AS1-L is associated with unfavorable prognosis in patients suffering from glioma.
    Shang F; Du SW; Ma XL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8950-8955. PubMed ID: 31696482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly expressed lncRNA FOXD3-AS1 promotes non-small cell lung cancer progression via regulating miR-127-3p/mediator complex subunit 28 axis.
    Zeng ZL; Zhu HK; He LF; Xu X; Xie A; Zheng EK; Ni JJ; Liu JT; Zhao GF
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2525-2538. PubMed ID: 32196603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis.
    Liu C; Li X; Hao Y; Wang F; Cheng Z; Geng H; Geng D
    Aging (Albany NY); 2020 May; 12(9):8680-8701. PubMed ID: 32396871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA AFAP1-AS1 Promotes Migration and Invasion of Non-Small Cell Lung Cancer via Up-Regulating IRF7 and the RIG-I-Like Receptor Signaling Pathway.
    Tang XD; Zhang DD; Jia L; Ji W; Zhao YS
    Cell Physiol Biochem; 2018; 50(1):179-195. PubMed ID: 30278439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
    Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
    Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA NCK1-AS1 promotes the proliferation, migration and invasion of non-small cell lung cancer cells by acting as a ceRNA of miR-137.
    Li J; Wu X; Cao W; Zhao J
    Am J Transl Res; 2020; 12(10):6908-6920. PubMed ID: 33194081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
    Zhou Y; Feng D; Gu X; Gao A; Liu Y
    Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.